A Comparison of Epidural Techniques for Labour Analgesia
NCT ID: NCT03065569
Last Updated: 2018-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2017-05-07
2018-05-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Programmed Intermittent Epidural Bolus Versus Continuous Infusion in Labour Analgesia
NCT03730753
Programmed Intermittent Epidural Bolus For Laboring Obstetrical Women
NCT03712735
ED90 of Epidural Bupivacaine With Lidocaine for the Initiation of Labor Analgesia
NCT05543694
Anesthesia Clinical Practice During Labour Neuraxial Analgesia
NCT07083167
Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes
NCT02008591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Epidural Technique
Epidural will be performed Initial dose of 16 mL of 0.125% bupivacaine will be given Upon patient request, rescue bolus based on protocol will be administered.
Bupivacaine
16 mL of 0.125% bupivacaine
Combined Spinal Epidural Technique
CSE will be performed Initial dose of 16 mL of 0.125% bupivacaine will be given Upon patient request, rescue bolus based on protocol will be administered.
Bupivacaine
16 mL of 0.125% bupivacaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine
16 mL of 0.125% bupivacaine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
19 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anton Chau
Clinical Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anton Chau, MD MMSc
Role: PRINCIPAL_INVESTIGATOR
UBC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BC Women's Hospital
Vancouver, British Columbia, Canada
British Columbia's Women's Hospital
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H16-03380
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.